Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods

被引：48

作者：

Cantón, E

Pemán, J

Gobernado, M

Viudes, A

Espinel-Ingroff, A

机构：

[1] Hosp Univ Fe, Unidad Microbiol Expt, Ctr Invest, Valencia 46009, Spain

[2] Hosp Univ Fe, Microbiol Serv, Valencia 46009, Spain

[3] VCU, Med Ctr, Div Infect Dis, Richmond, VA USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 04期

关键词：

D O I：

10.1128/AAC.49.4.1593-1596.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro activities of fluconazole or voriconazole plus terbinafine were evaluated against 20 Candida isolates by the checkerboard, time-kill, and Etest methods. Synergism (C. albicans, C glabrata, and C. tropicalis) and indifference (C. krusei) were observed. Correlation among methods was good. The Etest is a suitable method to determine drug interactions.

引用

收藏

页码：1593 / 1596

页数：4

相关论文

共 19 条

[1] In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species [J].

Afeltra, J ;

Meis, JFGM ;

Vitale, RG ;

Mouton, JW ;

Verweij, PE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :2029-2031

[2] In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model [J].

Andes, D ;

Marchillo, K ;

Stamstad, T ;

Conklin, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3165-3169

[3] TERBINAFINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL MYCOSES [J].

BALFOUR, JA ;

FAULDS, D .

DRUGS, 1992, 43 (02) :259-284

[4] In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans [J].

Barchiesi, F ;

Di Francesco, LF ;

Compagnucci, P ;

Arzeni, D ;

Giacometti, A ;

Scalise, G .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) :59-65

[5] In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles [J].

Barchiesi, F ;

DiFrancesco, LF ;

Scalise, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1812-1814

[6] Quality control limits for broth microdilution susceptibility tests of ten antifungal agents [J].

Barry, AL ;

Pfaller, MA ;

Brown, SD ;

Espinel-Ingroff, A ;

Ghannoum, MA ;

Knapp, C ;

Rennie, RP ;

Rex, JH ;

Rinaldi, MG .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3457-3459

[7]

Canton E, 2004, Rev Esp Quimioter, V17, P48

[8] Patterns of amphotericin B killing kinetics against seven Candida species [J].

Cantón, E ;

Pemán, J ;

Gobernado, M ;

Viudes, A ;

Espinel-Ingroff, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) :2477-2482

[9] FLUCONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL AND SYSTEMIC MYCOSES [J].

GRANT, SM ;

CLISSOLD, SP .

DRUGS, 1990, 39 (06) :877-916

[10]

Hoffman HL, 2002, EXPERT OPIN INV DRUG, V11, P409